5. Progressive supranuclear palsy Clinical trials / Disease details


Clinical trials : 95 Drugs : 119 - (DrugBank : 40) / Drug target genes : 65 - Drug target pathways : 108

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01537549
(ClinicalTrials.gov)
September 14, 20109/1/2012Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear PalsyAn Open-label Trial of Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy (PSP): Effect Upon Oxidative Damage and Mitochondrial BiomarkersProgressive Supranuclear PalsyDrug: alpha-lipoic acid and L-acetyl carnitineWeill Medical College of Cornell UniversityNULLCompleted40 Years75 YearsAll11Phase 1/Phase 2United States